Braeburn Pharmaceuticals, INC.
pharmaceutical company
Based in NJ
AI Overview
With $1.4M in lobbying spend across 32 quarterly filings, Braeburn Pharmaceuticals, INC is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $250K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $5K |
| 2023 | $160K |
| 2024 | $185K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Braeburn Pharmaceuticals, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
reducing stigma and promoting treatment of opioid use disorder
raising awareness of the benefits of medication assisted therapy (MAT)
ensuring patient access to MAT, including S.916- Protecting Patien
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.